FDA Inspection 1023630 — Matthew Danter, MD

Matthew Danter, MD — FEI 3013413812

The FDA completed an inspection of Matthew Danter, MD on Jun 2, 2017 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jun 2, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.